BioMarin Pharmaceutical Inc. (BMRN) PT Lowered to $85 at RBC Capital

September 17, 2024 6:16 AM EDT Send to a Friend
RBC Capital analyst Luca Issi lowered the price target on BioMarin ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login